DIA/FDA Biostatistics Industry and Regulator Forum

DIA Your Way! Join us virtually from the comfort of your home/office April 6-8 or watch later at a time that works for you. This event provides access to the materials for a full two months!

Back to Agenda

Challenges and Opportunities for the Quantitative Sciences in Medical Product Development and Evaluation

Session Chair(s)

Brenda Crowe, PhD

Associate Vice President, Statistics

Eli Lilly and Company, United States

Fairouz Makhlouf, PhD

Deputy Director, Office of Biostatistics, Office of Translational Science, CDER

FDA, United States

Plenary Session featuring Dr. Robert Califf

Speaker(s)

Speaker

Robert M. Califf, MD